4.6 Article

Using machine learning to predict individual patient toxicities from cancer treatments

Journal

SUPPORTIVE CARE IN CANCER
Volume 30, Issue 9, Pages 7397-7406

Publisher

SPRINGER
DOI: 10.1007/s00520-022-07156-6

Keywords

Vasomotor symptoms; Hot flashes; Breast cancer; Machine learning; Artificial intelligence; Survivorship

Funding

  1. Rethinking Clinical Trials (REaCT) program platform at the Ottawa Hospital - Ottawa Hospital Foundation

Ask authors/readers for more resources

Machine learning was utilized to identify early breast cancer patients with highest risk of developing severe vasomotor symptoms. Important variables in the model included the number of hot flashes per week, age, drug interventions for VMS, frequency of VMS inquiry during follow-up visits, and changes in breast cancer treatments due to VMS. A threshold of 17 hot flashes per week was identified as being more predictive of severe VMS.
Purpose Machine learning (ML) is a powerful tool for interrogating datasets and learning relationships between multiple variables. We utilized a ML model to identify those early breast cancer (EBC) patients at highest risk of developing severe vasomotor symptoms (VMS). Methods A gradient boosted decision model utilizing cross-sectional survey data from 360 EBC patients was created. Seventeen patient- and treatment-specific variables were considered in the model. The outcome variable was based on the Hot Flush Night Sweats (HFNS) Problem Rating Score, and individual scores were dichotomized around the median to indicate individuals with high and low problem scores. Model accuracy was assessed using the area under the receiver operating curve, and conditional partial dependence plots were constructed to illustrate relationships between variables and the outcome of interest. Results The model area under the ROC curve was 0.731 (SD 0.074). The most important variables in the model were as follows: the number of hot flashes per week, age, the prescription, or use of drug interventions to manage VMS, whether patients were asked about VMS in routine follow-up visits, and the presence or absence of changes to breast cancer treatments due to VMS. A threshold of 17 hot flashes per week was identified as being more predictive of severe VMS. Patients between the ages of 49 and 63 were more likely to report severe symptoms. Conclusion Machine learning is a unique tool for predicting severe VMS. The use of ML to assess other treatment-related toxicities and their management requires further study.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available